SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (948)	12/28/1998 11:39:00 PM
From: Rudy Saucillo	Read Replies (1) of 1477

MZ, the only info that I've seen (which of course is public info) is that there was a greater incidence of mortality in the Fiblast arm vs. placebo in the US trial. The safety committee has not observed this in the Euro stroke trial which was allowed to continue. Scios has pointed out that the greater incidence of mortality has not been directly tied to Fiblast use. Rudy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next